Exacerbations, mortality risk, and pharmacotherapy in COPD: Effect of 17 different drug combinations in a cohort of 495 patients
Int. Journal of Clinical Pharmacology and Therapeutics · 2025
DOI: 10.5414/cp204727 ↗Kurz gefasst
Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2025. Verfasst von Guoxin Wu und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Bronchodilator Agents.
Themen: COPD
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Wu, G., Guan, Z., Lv, Q., Ye, Y., He, J., Luo, J., Cai, Y., & Wu, Z. (2025). Exacerbations, mortality risk, and pharmacotherapy in COPD: Effect of 17 different drug combinations in a cohort of 495 patients. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204727
Vancouver
Wu G, Guan Z, Lv Q, Ye Y, He J, Luo J, et al. Exacerbations, mortality risk, and pharmacotherapy in COPD: Effect of 17 different drug combinations in a cohort of 495 patients. Int. Journal of Clinical Pharmacology and Therapeutics. 2025. doi:10.5414/cp204727
BibTeX
@article{Wu2025,
author = {Wu, Guoxin and Guan, Ziyun and Lv, Quankun and Ye, Yi and He, Jiacheng and Luo, Jianwen and Cai, Yanglin and Wu, Zhixin},
title = {Exacerbations, mortality risk, and pharmacotherapy in COPD: Effect of 17 different drug combinations in a cohort of 495 patients},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2025},
doi = {10.5414/cp204727}
}
EUVIMED